GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » EV-to-FCF

Nuvation Bio (Nuvation Bio) EV-to-FCF : 0.00 (As of Apr. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Nuvation Bio's Enterprise Value is $0.00 Mil. Nuvation Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2021 was $-44.86 Mil. Therefore, Nuvation Bio's EV-to-FCF for today is 0.00.

The historical rank and industry rank for Nuvation Bio's EV-to-FCF or its related term are showing as below:

NUVB.WS's EV-to-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 4.27
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-04-26), Nuvation Bio's stock price is $0.8074. Nuvation Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $0.000. Therefore, Nuvation Bio's PE Ratio (TTM) for today is N/A.


Nuvation Bio EV-to-FCF Historical Data

The historical data trend for Nuvation Bio's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio EV-to-FCF Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
EV-to-FCF
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
EV-to-FCF Get a 7-Day Free Trial - -79.07 -30.72 -30.61 -

Competitive Comparison of Nuvation Bio's EV-to-FCF

For the Biotechnology subindustry, Nuvation Bio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's EV-to-FCF falls into.



Nuvation Bio EV-to-FCF Calculation

Nuvation Bio's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/-44.855
=0.00

Nuvation Bio's current Enterprise Value is $0.00 Mil.
Nuvation Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-44.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB.WS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Nuvation Bio's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.8074/0.000
=N/A

Nuvation Bio's share price for today is $0.8074.
Nuvation Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Nuvation Bio EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.